Royalty Report: Drugs, Stem cells, Chemicals – Collection: 268577

$100.00

Curated Royalty Rate Report
Created On: 2020-07-15, Record Count: 3

Description

This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Created On: 2020-07-15
Record Count: 3

Primary Industries

  • Drugs
  • Stem cells
  • Chemicals
  • AgroChemical
  • Pharmaceuticals
  • Fertilizer
  • Research

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 268577

License Grant
As part of the Settlement Agreement, Licensor assigned ownership of USPN 9,816,071 and Patent Application No. 15/729,038, No. 14/244,084, and International Patent Serial No. PCT/US 15/24045 to Licensee and will provide additional consideration in the form of a royalty payment.
License Property
Intellectual Property (the “IP”) means USPN 9,816,071 and Patent Application No. 15/729,038, Patent Application No. 14/244,084, and International Patent Serial No. PCT/US 15/24045.

The Copper/Zinc Superoxide Dismutase (SOD) Formulation for the Treatment of Traumas Including Amyotrophic Lateral Sclerosis Patent Application No. 14/244,084

9,816,071 – Replication of undifferentiated cells in a weightless environment, uses thereof and a facility for such replication and the acceleration of the evolution of plants and animals

Field of Use
This agreement pertains to the medical industry relating to stem cell research and development.

IPSCIO Record ID: 27526

License Grant
The Licensor grants the Licensor the exclusive worldwide and intergalactic rights to develop, manufacture, have made, use, sell, offer for sale, distribute, otherwise dispose of the IP and any and all products developed by the IP. The License granted will apply to manufacturing, commercial opportunities and/or supply and/or research for products which may be researched and developed for fertilizers, the nutrition and the fortification of plants, and for humans and animals such as the remediation of radiation of astronauts and other oxidative stress conditions discovered in a micro/zero gravity environment.
License Property
The Licensor has developed and is the owner of certain technologies, drawings and documentation containing trade secrets and know-how relative to specific applications of the intellectual Property in connection with 'ALS SOD Ligand Formula' including a patent application, COPPER/ZINC SUPEROXIDE DISMUTASE (SOD) FORMULATION FOR THE TREATMENT OF TRAUMAS INCLUDING AMYOTROPHIC LATERAL SCLEROSIS.

The BAM-FX composition is highly useful as a nutrient additive that enhances a plant’s immune system, may fortify against disease and promotes growth. The basis of which is the ability of the ionized ligand system to deliver selected minerals into a plant or other complex organism systemically at the cellular level.

We are also the licensee of a patent application that pertains to the use of an artificial Superoxide Dismutase (“SOD”) compositions for the treatment of several plant and animal diseases, including amyotrophic lateral sclerosis (also known as ALS disease). Superoxide is naturally produced by plants and animals, including humans, and its production is accelerated in times of trauma or stress. SOD is produced by the cells to counteract the effects of an over-production of superoxide. Adequate amounts of SOD may increase life-span in humans and may be capable of remediating (and saving) severely stressed plants. This patent application discusses an artificial SOD that can be easily applied and used for treating over-production of superoxide, particularly ALS and other neural disorders. The artificial SOD at issue here is less expensive to manufacture than other artificial SODs and has a significantly lighter molecular weight. Animal and human studies of the SOD are being discussed on an ongoing basis with NASA and academic entities.

Field of Use
The License granted shall apply to any manufacturing, commercial opportunities and/or supply and/or research for products which may be researched and developed by Licensee for fertilizers, the nutrition and the fortification of plants and for humans and animals such as the remediation of radiation of astronauts and other oxidative stress conditions discovered in a micro/zero gravity environment.

IPSCIO Record ID: 204653

License Grant
Israeli University granted to Licensee an exclusive license to (i) the inventions, know-how and results made with respect to the stem cell technology developed by the team led in the course of the performance of the research, and the patents and pending patent applications owned by University, and (ii) the results of further research to be performed by the same team on the development of the stem cell technology.
License Property
The inventions, know-how and results made with respect to the stem cell technology relating to processes for the transformation of bone marrow and cord blood stem cells into neuron-like and glial-like cells.
Field of Use
This agreement pertains to stem cell technology.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.